Bile Duct Diseases

What are bile duct diseases?

The bile ducts form a network of small tubes that connect the liver, gallbladder and small intestine. Their main job is to carry bile, a digestive fluid made in the liver, to the intestine, where it helps break down fats and absorb vitamins.

Bile is stored in the gallbladder and released into the small intestine after meals, especially when fatty foods are eaten. It also helps the body remove waste such as bilirubin and excess cholesterol.

Bile duct diseases occur when this flow of bile becomes blocked or slowed. This may happen due to gallstones, narrowing (strictures), infections, inflammation or, in some cases, growths or tumours. When bile cannot flow properly, it can back up into the liver and cause pain, jaundice and potentially serious liver damage if left untreated.

Types of bile-duct diseases

Several conditions can affect the bile ducts, either by blocking bile flow or damaging the ducts themselves. These are the main types:

• Choledocholithiasis — this refers to gallstones or other deposits within the common bile duct. Most stones originate in the gallbladder and move into the duct, though some may form there directly. Cholesterol stones are the most common type, while pigment stones, made from calcium and bilirubin, occur less often. These stones can block bile flow, causing pain, jaundice and infection.

• Cholangitis — this is an infection and inflammation of the bile ducts, usually occurring when bile flow is obstructed by a stone, tumour or narrowing. Patients often present with fever, abdominal pain and yellowing of the skin (jaundice). Prompt treatment is important to prevent complications such as sepsis, which can be life-threatening.

• Congenital bile-duct disorders — Choledochal cysts (pre-cancerous cystic degeneration of the bile duct) usually appear in infancy or early childhood but can also be found in adults. They cause repeated bouts of infection (cholangitis) and certain types have a high risk of malignant change

• Tumours and neoplasms of the bile ducts — the bile ducts may also develop tumours, which can be benign (non-cancerous) or malignant (cancerous). Cholangiocarcinoma is a serious cancer that arises from the bile ducts and can obstruct bile flow or spread to nearby organs.

• Chronic bile duct diseases — conditions such as primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) are long-term inflammatory diseases that damage and scar the bile ducts over time. These autoimmune conditions can eventually cause cirrhosis and liver failure if untreated, and patients are at high risk of developing bile duct cancer (cholangiocarcinoma)

What causes bile duct diseases?

Bile duct diseases arise when the normal flow of bile, from the liver to the gallbladder and onward to the small intestine, is disrupted. This obstruction or inflammation can occur due to a range of structural, infectious or inflammatory causes. The most frequent cause of biliary obstruction is gallstones, but several other factors can also contribute.

Common causes include:

• Gallstones (choledocholithiasis) — gallstones are the leading cause of bile duct blockage. Stones that form in the gallbladder may migrate into the common bile duct, obstructing bile flow and causing pain, jaundice or infection.

• Tumours — both benign and malignant growths within the bile ducts can directly block bile flow. Tumours in neighbouring organs, such as the pancreas, liver or gallbladder  may also press on or invade the ducts, leading to secondary obstruction. Pancreatic head cancer is one of the most frequent malignant causes of biliary blockage.

• Strictures — a stricture is an abnormal narrowing of the bile duct. It may result from prior surgery, inflammation, trauma, cancer or congenital malformations. Strictures can partially or completely obstruct bile flow and often require imaging and intervention to relieve the blockage.

• Parasitic infections — in certain regions, parasites such as roundworms (Ascaris lumbricoides) or liver flukes (Clonorchis sinensis, Fasciola hepatica) may enter the bile ducts, causing obstruction and inflammation. These infections are more common in parts of Asia and developing regions where foodborne transmission occurs.

• Biliary sludge and microlithiasis — thickened bile containing cholesterol crystals, calcium salts, and other particles can accumulate and form biliary sludge. Over time, this may reduce bile flow or evolve into stones within the ducts.

• Autoimmune and systemic diseases — conditions such as primary sclerosing cholangitis may lead to bile duct strictures and repeated bouts of cholangiti and eventually bile duct cancer

When bile flow is impeded, pressure builds up within the biliary system. This causes dilation of the bile ducts and leakage of bile components, including bilirubin, into the bloodstream, producing jaundice, seen as yellowing of the skin and eyes.

Obstruction can also allow intestinal bacteria to enter the biliary tract, where stagnant bile provides an ideal environment for infection. If bacteria spread into the bloodstream, this may lead to cholangitis, liver abscesses or sepsis, which require urgent medical attention.

What are the signs and symptoms of bile duct diseases?

Bile duct diseases can present with symptoms that closely resemble other digestive and liver disorders. Because the bile ducts, liver and gallbladder work together as part of the same system, problems in one area often affect the others. When bile flow is obstructed or reduced, bile may build up in the liver, leading to inflammation and impaired liver function. This overlap explains why many bile duct disorders share symptoms with hepatic conditions.

Common signs and symptoms include:

• Abdominal pain, typically in the upper right quadrant or upper middle abdomen, which may radiate to the back or shoulder.

• Fever and chills, especially if infection or cholangitis is present.

• Nausea and vomiting, often accompanying acute obstruction or infection.

• Jaundice, a yellowing of the skin and eyes due to increased bilirubin levels in the bloodstream.

• Dark urine, resulting from excess bilirubin being excreted through the kidneys.

• Pale or clay-coloured stools, caused by reduced bile reaching the intestines.

• Loss of appetite and unintended weight loss, particularly in chronic or malignant conditions.

• Itching (pruritus), due to bile salts accumulating in the bloodstream.

• Fatigue or lethargy, often linked to the liver’s reduced ability to filter toxins effectively.

In severe or advanced cases, patients may also experience confusion, fluid retention (ascites) or bleeding tendencies due to impaired liver function. These complications indicate significant biliary obstruction or liver damage and require urgent medical attention.

Who is at risk of bile duct diseases?

Certain groups of individuals are more likely to develop bile duct diseases due to underlying medical conditions, lifestyle factors or environmental exposures. These risk factors either increase the likelihood of bile duct obstruction or make the biliary system more susceptible to inflammation and infection.

Groups at higher risk include:

• Individuals prone to gallstones — people with risk factors for gallstone formation are more likely to experience bile duct obstruction caused by migrating stones. Gallstones are more common in older adults, women (particularly those who are pregnant or taking oestrogen-based medication), individuals who are overweight or obese and those with high cholesterol or a family history of gallbladder disease. Rapid weight loss (such as after weight-loss surgery) and diets high in fat and sugar can also increase risk.

• People with HIV/AIDS — patients with advanced HIV infection may develop AIDS cholangiopathy, a condition in which chronic infections of the biliary tract lead to inflammation and strictures. The weakened immune system increases vulnerability to opportunistic organisms that can infect or damage the bile ducts.

• Those with a history of abdominal or biliary surgery — patients who have previously undergone abdominal or biliary surgery are at a higher risk of developing bile duct problems. In some cases, injury to the bile ducts can occur during gallbladder or liver surgery, leading to postoperative narrowing known as an iatrogenic stricture. 

What are the complications of bile duct diseases?

If bile duct diseases are not treated promptly, they can lead to serious and sometimes life-threatening complications. These occur when bile cannot flow normally, causing pressure build-up, infection or progressive liver damage. The severity of complications depends on the cause, how long the blockage lasts and the overall health of the liver.

• Cholangitis — when bile flow is obstructed, bacteria may enter the ducts and cause infection. This leads to acute cholangitis, marked by fever, jaundice and upper abdominal pain. Without urgent treatment, it can progress to sepsis, dangerously low blood pressure and organ failure.

• Liver damage and cirrhosis — prolonged blockage causes bile to back up into the liver, damaging liver cells. Over time, this scarring (fibrosis) can progress to cirrhosis, where normal liver tissue is replaced by scar tissue, leading to impaired liver function or failure.

• Gallbladder inflammation — blocked bile flow can inflame the gallbladder, a condition known as cholecystitis. It causes pain, fever and tenderness, and in severe cases may result in abscess formation or rupture.

• Pancreatitis — gallstones or tumours near the lower bile duct can block the shared outlet of the bile and pancreatic ducts. This may trigger acute pancreatitis, which presents with severe abdominal pain, nausea and vomiting.

• Biliary cirrhosis and portal hypertension — chronic obstruction within the liver can lead to secondary biliary cirrhosis and increased pressure in the portal vein. This may cause fluid build-up in the abdomen (ascites), enlarged veins in the oesophagus (varices), and spleen enlargement (splenomegaly).

• Malabsorption and vitamin deficiency — reduced bile flow affects fat digestion and absorption of fat-soluble vitamins (A, D, E, and K), leading to weak bones, easy bruising or vision problems over time.

• Bile leaks and abscesses — after surgery or injury, bile may leak into the abdominal cavity, irritating nearby tissues or forming abscesses that require drainage.

• Increased cancer risk — long-standing inflammation of the bile ducts, as seen in primary sclerosing cholangitis or certain infections, raises the risk of developing bile duct cancer (cholangiocarcinoma).

When to seek urgent medical care

Immediate medical attention is required if you experience:

• Sudden onset of severe upper abdominal pain
• Fever with chills and jaundice
• Persistent vomiting or confusion
• Yellowing of the eyes or skin that worsens rapidly
• Signs of shock, such as low blood pressure, rapid heartbeat or fainting

Prompt diagnosis and intervention can prevent many of these complications and improve long-term outcomes.

How are bile duct diseases diagnosed?

Because the symptoms of bile duct diseases frequently overlap with those of liver or gallbladder disorders, a thorough diagnostic approach is required. This typically involves a combination of clinical assessment, laboratory testing and imaging or endoscopic procedures.

Clinical assessment

A doctor will begin with a detailed medical and surgical history, including any previous gallbladder, liver or pancreatic operations. You may be asked about the onset, duration and nature of your symptoms, including fever, jaundice, itching or weight loss. During a physical examination, the doctor will check your upper right abdomen for tenderness, swelling or pain. They may also look for signs of liver or spleen enlargement and fluid accumulation (ascites).

Blood and laboratory tests

These help distinguish biliary disease from other conditions and identify infection, obstruction, or liver inflammation. Common tests include:

• Complete blood count (CBC) — detects infection or inflammation through elevated white blood cell levels.

• Liver function tests (LFTs) — measure enzymes such as ALT, AST, ALP and GGT to assess liver and bile flow function.

• Bilirubin levels — high levels suggest bile flow obstruction or liver dysfunction.

• Alkaline phosphatase (ALP) and γ-glutamyl transferase (GGT) — elevated levels are often seen in bile duct obstruction or cholestasis.

• Blood cultures — used to detect bacteria in the bloodstream, especially in suspected cholangitis.

• Tumour markers — substances such as CA 19-9, CEA, and AFP may be tested when bile duct or pancreatic cancer is suspected.

Imaging and specialised diagnostic procedures

Since biliary obstruction or anatomical abnormalities may underlie symptoms, imaging plays a crucial role.

• Ultrasound — often the first test performed. It can detect gallstones, duct dilation and signs of obstruction.

• CT or MRI scans — provide detailed images of the liver, bile ducts and surrounding organs. A specialised MRI technique called Magnetic Resonance Cholangiopancreatography (MRCP) gives a clear, non-invasive view of the bile ducts.

• Cholescintigraphy (HIDA scan) — a radioactive tracer is injected into the bloodstream to assess bile flow from the liver to the small intestine, useful for evaluating bile leaks or gallbladder function.

• Liver biopsy — occasionally performed when autoimmune, inflammatory or malignant causes are suspected. A small tissue sample is taken from the liver to examine bile duct injury or scarring.

How are bile duct diseases treated?

Treatment depends on the underlying cause and the severity of obstruction or infection. Many patients require admission for observation, pain control, intravenous fluids, and antibiotics if infection is suspected. Urgent intervention is essential in those with acute cholangitis, sepsis, or peritonitis.

Gallstone obstruction (choledocholithiasis)

• ERCP (Endoscopic Retrograde Cholangiopancreatography) — most commonly used method in most cases to achieve biliary drainage and remove stones using baskets/balloons; intraductal lithotripsy may be used for large or impacted stones.

• Endoscopic sphincterotomy — a small incision is made at the sphincter of Oddi (the muscle controlling the bile duct opening) during ERCP. This allows easier removal of stones from the bile duct and helps prevent future blockages.

• PTC — when ERCP is not feasible. It involves the insertion of a drainage tube into the bile duct via a needle puncture through the abdominal wall.  

• Cholecystectomy — laparoscopic removal of the gallbladder is recommended after duct clearance to prevent further stones and recurrent biliary events. Most people live normally without a gallbladder.

• Antibiotics — indicated when infection is present (e.g., cholangitis). Therapy is guided by local protocols and cultures; early source control with ERCP is critical.

Benign or malignant biliary strictures

• Endoscopic balloon dilatation and stenting — during an endoscopic procedure, the narrowed section of the bile duct is gently widened using a balloon. A stent is then inserted to keep the duct open and maintain bile flow. Plastic stents are usually replaced at regular intervals, while self-expanding metal stents (SEMS) are used for longer-term support, especially in malignant strictures.

• Percutaneous transhepatic drainage — if standard endoscopic access (ERCP) is not possible, bile drainage may be achieved by inserting a tube through the skin into the liver (percutaneous transhepatic drainage). These methods help relieve blockage and resolve infection.

• Surgery for benign strictures — in complex or recurrent cases, or when injury has occurred during previous surgery, a reconstructive operation called biliary-enteric anastomosis (for example, Roux-en-Y hepaticojejunostomy) may be performed to permanently restore bile flow.

Tumours (bile duct, pancreatic, ampullary, or gallbladder)

Management depends on tumour type, stage and resectability.

• Surgical resection — localised cholangiocarcinoma (bile-duct cancer) may be treated by removing part of the liver or bile duct. Tumours in the lower bile duct or pancreatic head may require a Whipple procedure (pancreaticoduodenectomy). Selected cases of perihilar cholangiocarcinoma may be eligible for liver transplantation at specialised centres after neoadjuvant therapy. Gallbladder cancers that are confined to the gallbladder wall can often be managed with a radical cholecystectomy.

• Systemic therapy — for advanced or inoperable tumours, chemotherapy using gemcitabine and platinum-based combinations is preferred. Targeted drugs and immunotherapy may be added when certain genetic mutations are detected.

• Radiation/locoregional options — these may be offered in selected cases to relieve symptoms or control local tumour growth.

• Biliary drainage and palliation — when tumours block bile flow, endoscopic or percutaneous stenting helps relieve jaundice, itching and infection. Palliative bypass surgery may sometimes be needed.

Congenital abnormalities

• Choledochal cysts — these are treated by complete cyst removal and reconstruction of the bile drainage using a Roux-en-Y hepaticojejunostomy to prevent infection and reduce future cancer risk.

Chronic cholestatic and autoimmune bile-duct diseases (for completeness)

• Primary biliary cholangitis (PBC) — the main treatment is ursodeoxycholic acid. Patients who do not respond adequately may receive additional medication such as obeticholic acid or fibrates. Itching caused by bile retention can be managed with bile-acid binding agents.

• Primary sclerosing cholangitis (PSC) — there is no proven cure, but dominant narrowings in the bile ducts can be widened through endoscopic dilatation. Care focuses on treating complications, monitoring for bile-duct or bowel cancer, and evaluating for liver transplantation when necessary.

Supportive and emergency care across causes

Supportive care focuses on stabilising patients, relieving symptoms, and preventing complications while addressing the underlying cause of bile-duct disease.

• Sepsis management — in cases of acute cholangitis or infection, treatment follows standard sepsis protocols, including prompt administration of antibiotics, intravenous fluids and urgent bile drainage, usually through endoscopic retrograde cholangiopancreatography (ERCP) or PTC.

• Nutritional and pruritus management — patients with prolonged bile obstruction may need supplements for fat-soluble vitamins (A, D, E and K). Itching due to bile accumulation can be managed with bile-acid binding agents such as cholestyramine.

• Pain control and anti-emetics — appropriate pain relief and anti-emetic medications are given as needed to improve comfort and recovery.

• Follow-up — regular monitoring of liver function tests, timely stent replacement (if used), and management of underlying causes, such as gallstones or strictures, are essential to prevent recurrence. Definitive surgery, such as gallbladder removal, may be recommended after stone-related events.

Summary

Bile duct diseases refer to a range of conditions that disrupt the normal flow of bile from the liver to the small intestine. These may result from gallstones, narrowing (strictures), infections, tumours or congenital abnormalities. Depending on the cause, the effects can range from mild discomfort to serious complications such as cholangitis, cirrhosis, or sepsis. Because bile plays an essential role in digestion and the removal of toxins, any blockage can quickly affect liver function and overall health.

Accurate diagnosis is crucial and typically involves a combination of blood tests, imaging such as ultrasound or MRCP and specialised procedures like ERCP. Treatment is tailored to the underlying cause: stones can often be removed endoscopically, narrowed ducts may be widened or stented and structural problems or tumours may require surgical correction. With timely and appropriate care, most bile duct conditions can be effectively treated, significantly reducing the risk of long-term liver damage.

If you are experiencing persistent abdominal pain, yellowing of the skin or eyes, or any symptoms that may indicate a bile duct problem, schedule a consultation with Tan Siong San Surgery for expert diagnosis and comprehensive management of bile duct and gallbladder diseases.